IBIO, Inc. Banner Image

IBIO, Inc.

  • Ticker IBIO
    Exchange NYSE More
  • Industry Biotechnology More
  • Sector Healthcare More
IBIO, Inc. Logo Image
  • 11-50 Employees
  • Based in New York City, New York
iBio is developing proprietary products for the treatment of a range of fibrotic diseases including idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. IBIO-CFB03, produced using the Company's proprietary gene expression technology, is the first product candidate from this program being advanced for IND development. The Company also offers proprietary products and productMore licenses to others based on its proprietary technologies, providing collaborators full support for turn-key implementation of its technology for protein therapeutics and vaccines.
4.8 / 5.0 (204)

IBIO, Inc. reports have an aggregate usefulness score of 4.8 based on 204 reviews.

IBIO, Inc.

Most Recent Annual Report

IBIO, Inc.
MOST RECENT 2022 Annual Report and Form 10K

IBIO, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

IBIO, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!